Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Global generic drug market expected to reach USD 380.60 billion by 2021, growing at a CAGR of 10.8 % between 2016 and 2021.

06-Oct-2016 | Number of pages: 110 | Report Code: ZMR-212 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the generic drug market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the generic drug market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the generic drug market on a global level.

This report offers comprehensive coverage on global generic drug market along with, market trends, drivers, and restraints of the generic drug market. This report includes a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the generic drug market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared by using data sourced from in-house databases, secondary and primary research team of industry experts. Research analysts and consultants cooperate with leading companies of the concerned domain to verify every value of data exists in this report.

The study provides a decisive view on the generic drug market by segmenting the market based on brand, therapeutic and regions. All these segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The brand based market covered under this study includes pure generic drugs and branded generic drugs. The therapeutic application based market covered under this study includes central nervous system (CNS), cardiovascular, dermatology, oncology, respiratory and others. This report also includes the current and forecast demand for the region of North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Key operating players for generic drugs market are Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Abbott Healthcare Pvt Ltd, Actavis Pharmaceuticals and Sun Pharmaceuticals.

This report segments the generic drugs market as follows:

Generic Drugs Market: Brand Segment Analysis

  • Pure generic drugs
  • Branded generic drugs

Generic Drugs Market: Therapeutic Application Segment Analysis

  • Central nervous system (CNS)
  • Cardiovascular
  • Dermatology
  • Oncology
  • Respiratory
  • Others.

Generic Drugs Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Cell Culture Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-705 | Report Format:

Global Cell Culture Market: Overview The global cell culture market is escalating due the high demand for cell cultures throughout the global. The culturing of the live animal and plant cells in an artificial environment is called as cell culture. The culturing of the cells has a number of appli...Read More

Antibody Production Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-695 | Report Format:

Global Antibody Production Market: Overview The immune system produces antibodies secreted in the blood, which are protein molecules produced in response to the antigens, foreign particles such as virus, fungi, and bacteria. The antibodies function by neutralizing or inhibiting the antigen activ...Read More

Oral Antidiabetic Drugs Market by Drugs Class Category (Sulfonylureas, Meglitinides, Biguanides and Alpha-glucosidase inhibitors) for Type 2 Diabetes mellitus - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Jan-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-687 | Report Format:

The report covers forecast and analysis for the oral antidiabetic drugs market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based on revenue (USD billion). The study includes drivers and restraints of the oral antidiabetic drugs m...Read More

Sample Preparation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-644 | Report Format:

Global Sample Preparation Market: Overview In the recent years, the global sample preparation market has grown and developed to a large extent. In general terms, sample preparation is a technique wherein any sample of an item is analyzed and then used for preparation. Differentiation is seen on ...Read More

Antifungal Drug Market by Drug Type (Echinocandins, Azoles, Ployenes, Allylamines and Others) and by Dosage Form (Powders, Ointments, Drugs and Pastes) for Aspergillosis, Dermatophytosis, Candidiasis and Others Infection - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021

Dec-2016 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-534 | Report Format:

The report covers forecast and analysis for the antifungal drug market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the antifungal drug market along wit...Read More

Choose License Type: